Equity Profile

TFX

Teleflex Incorporated

Health CareHealth Care Equipment$5.7B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Teleflex Incorporated (TFX) is a global provider of medical technologies, specializing in innovative healthcare equipment. With a focus on improving patient outcomes, the company plays a crucial role in the healthcare sector, particularly in areas like surgical and respiratory care.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

TFX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

-0.76%

Avg Stock Reaction

-4.06%

Last Quarter Recap

In Q1-2026, Teleflex reported an EPS of $1.39, exceeding expectations by nearly 15%. The stock reacted positively, gaining over 6% the following day.

Management Promises & Guidance

Focus on expanding product lines in surgical care.
Commitment to improving operational efficiencies.
Plans to enhance customer service and support.

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's recent performance and positive EPS surprise.

Bull Case

If Teleflex continues its trend of beating EPS estimates and shows strong revenue growth, it could signal robust demand for its products.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to last quarter's surprise?

The market will closely watch EPS as a key indicator of profitability and to gauge the company's ongoing performance.

What guidance will management provide regarding revenue growth for the upcoming quarters?

Future revenue guidance will be crucial for investor confidence and could significantly impact stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Teleflex's ability to leverage recent product innovations to drive revenue growth this quarter.

Supporting Evidence

The company has a strong track record of beating EPS estimates, with an 88% beat rate over the last eight quarters.

Recent trends in healthcare spending suggest increased demand for medical technologies, which could benefit Teleflex.

Options pricing indicates a higher expected move, suggesting that investors anticipate significant developments.

Key Risk

If revenue growth comes in below expectations, it could challenge the optimistic outlook currently priced into the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on the company's ability to maintain profitability and growth amid market pressures.

Bull Confirmed If

An EPS of $1.50 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $1.20 would confirm the bear case, suggesting potential challenges in revenue generation.

Pre-Earnings Positioning

Options Market

Implied Move

±15.64%

Historical Avg

±10.3%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±15.6% while TFX has averaged ±10.3% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

49.8%

Calls (2K)P/C Ratio: 1.31Puts (2K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Teleflex beats expectations, history suggests a potential stock increase of around 6% on the following day, confirming strong demand.

In-Line / Cautious

If results are in line with expectations but management's commentary is cautious, the stock may see muted movement as investors reassess growth prospects.

Miss

Should the company miss expectations, history indicates a potential decline of around 6.37%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on operational efficiencies and cost management.
3Insights into market demand for Teleflex's key product lines.
4Guidance on revenue expectations for the next quarter.
5Responses to any potential challenges in the healthcare market.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

Insider activity

PreviewView

Jul

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

TFX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

-0.76%

Avg Stock Reaction

-4.06%

Last Quarter Recap

In Q1-2026, Teleflex reported an EPS of $1.39, exceeding expectations by nearly 15%. The stock reacted positively, gaining over 6% the following day.

Management Promises & Guidance

Focus on expanding product lines in surgical care.
Commitment to improving operational efficiencies.
Plans to enhance customer service and support.

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's recent performance and positive EPS surprise.

Bull Case

If Teleflex continues its trend of beating EPS estimates and shows strong revenue growth, it could signal robust demand for its products.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to last quarter's surprise?

The market will closely watch EPS as a key indicator of profitability and to gauge the company's ongoing performance.

What guidance will management provide regarding revenue growth for the upcoming quarters?

Future revenue guidance will be crucial for investor confidence and could significantly impact stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Teleflex's ability to leverage recent product innovations to drive revenue growth this quarter.

Supporting Evidence

The company has a strong track record of beating EPS estimates, with an 88% beat rate over the last eight quarters.

Recent trends in healthcare spending suggest increased demand for medical technologies, which could benefit Teleflex.

Options pricing indicates a higher expected move, suggesting that investors anticipate significant developments.

Key Risk

If revenue growth comes in below expectations, it could challenge the optimistic outlook currently priced into the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on the company's ability to maintain profitability and growth amid market pressures.

Bull Confirmed If

An EPS of $1.50 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $1.20 would confirm the bear case, suggesting potential challenges in revenue generation.

Pre-Earnings Positioning

Options Market

Implied Move

±15.64%

Historical Avg

±10.3%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±15.6% while TFX has averaged ±10.3% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

49.8%

Calls (2K)P/C Ratio: 1.31Puts (2K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Teleflex beats expectations, history suggests a potential stock increase of around 6% on the following day, confirming strong demand.

In-Line / Cautious

If results are in line with expectations but management's commentary is cautious, the stock may see muted movement as investors reassess growth prospects.

Miss

Should the company miss expectations, history indicates a potential decline of around 6.37%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on operational efficiencies and cost management.
3Insights into market demand for Teleflex's key product lines.
4Guidance on revenue expectations for the next quarter.
5Responses to any potential challenges in the healthcare market.